A Randomized Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS With Non RBC Transfusion Dependent Anemia and Without Del 5q
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms EPO-PRETAR
- 01 Feb 2018 Status changed from not yet recruiting to recruiting.
- 11 Dec 2017 Planned initiation date changed from 1 Dec 2017 to 1 Jan 2018.
- 16 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.